We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
New Brands to Boost Colgate's Personal Care Range in 2018
Read MoreHide Full Article
Colgate-Palmolive Co. (CL - Free Report) has signed agreements to acquire two professional skin care brands, PCA Skin and EltaMD. The acquisitions are in sync with Colgate’s strategy to focus on high-margin oral care, personal care and pet nutrition businesses.
While the terms of the deals remain under cover, management expects both transactions to close in the first quarter of 2018. However, the company does not expect the acquisitions of the fastest-growing professional skin care brands to influence its earnings in 2018.
PCA Skin provides medical-grade in-office and take-home skin care products. The brand is also supported by highly professional dermatologists,plastic surgeons and aestheticians. EltaMD is a leader in physician-dispensed sun care services. Together, these brands are expected to generate about $100 million sales in 2017.
Having nearly the same size, these brands are mainly distributed in the U.S., China and certain other international markets, through professional skin care channels and online.
Following the acquisitions, Colgate plans to operate these brands separately. These are likely to open Colgate’s doors to the professional skin care market, strengthening the company’s global personal care business. Moreover, the buyouts will enhance its presence in the premium global skin care category as these brands have complementary product portfolios and sales forces, and comparable distribution channels.
Furthermore, Colgate’s decade-long heritage of delivering strong recommendations by professional experts to its customers should benefit the high-growth, higher-margin brands.
Colgate’s Strategic Values
Colgate-Palmolive commands a market-leading position in the oral care and personal care product categories. Colgate’s continued global brand recognition and focus on product innovations and in-store implementations enhance its profitability and increases consumer satisfaction.
Colgate closed trading at $74.85, yesterday. Overall, the stock has gained nearly 4.9% in the last three months, against the industry’s decline of 0.4%.
In its last reported third quarter of 2017, this Zacks Rank #4 (Sell) company posted in-line earnings and topped sales estimates. Increased raw material and packaging costs restrained margins. The oral segment of Colgate faced a downturn as consumers shifted to Ayurvedic substitutes. Consequently, it had to resort to different strategic initiatives and incurred higher costs.
Meredith Corporation has an average positive earnings surprise of 7.1% for the trailing four quarters and has a long-term earnings growth rate of 8%.
Flowers Foods, Inc.’s (FLO - Free Report) average positive earnings surprise is 2.8% for the trailing four quarters. It has a long-term earnings growth rate of 6.1%.
Conagra Brands Inc. (CAG - Free Report) delivered a positive average earnings surprise of 6.9% and has a long-term earnings growth rate of 7%.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
New Brands to Boost Colgate's Personal Care Range in 2018
Colgate-Palmolive Co. (CL - Free Report) has signed agreements to acquire two professional skin care brands, PCA Skin and EltaMD. The acquisitions are in sync with Colgate’s strategy to focus on high-margin oral care, personal care and pet nutrition businesses.
While the terms of the deals remain under cover, management expects both transactions to close in the first quarter of 2018. However, the company does not expect the acquisitions of the fastest-growing professional skin care brands to influence its earnings in 2018.
PCA Skin provides medical-grade in-office and take-home skin care products. The brand is also supported by highly professional dermatologists,plastic surgeons and aestheticians. EltaMD is a leader in physician-dispensed sun care services. Together, these brands are expected to generate about $100 million sales in 2017.
Having nearly the same size, these brands are mainly distributed in the U.S., China and certain other international markets, through professional skin care channels and online.
Following the acquisitions, Colgate plans to operate these brands separately. These are likely to open Colgate’s doors to the professional skin care market, strengthening the company’s global personal care business. Moreover, the buyouts will enhance its presence in the premium global skin care category as these brands have complementary product portfolios and sales forces, and comparable distribution channels.
Furthermore, Colgate’s decade-long heritage of delivering strong recommendations by professional experts to its customers should benefit the high-growth, higher-margin brands.
Colgate’s Strategic Values
Colgate-Palmolive commands a market-leading position in the oral care and personal care product categories. Colgate’s continued global brand recognition and focus on product innovations and in-store implementations enhance its profitability and increases consumer satisfaction.
Colgate closed trading at $74.85, yesterday. Overall, the stock has gained nearly 4.9% in the last three months, against the industry’s decline of 0.4%.
In its last reported third quarter of 2017, this Zacks Rank #4 (Sell) company posted in-line earnings and topped sales estimates. Increased raw material and packaging costs restrained margins. The oral segment of Colgate faced a downturn as consumers shifted to Ayurvedic substitutes. Consequently, it had to resort to different strategic initiatives and incurred higher costs.
Stocks to Consider
Some better-ranked stocks in the Consumer Staples sector are Meredith Corporation , Flowers Foods, Inc.(FLO - Free Report) and Conagra Brands Inc.(CAG - Free Report) , each carrying a Zacks Rank# 2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Meredith Corporation has an average positive earnings surprise of 7.1% for the trailing four quarters and has a long-term earnings growth rate of 8%.
Flowers Foods, Inc.’s (FLO - Free Report) average positive earnings surprise is 2.8% for the trailing four quarters. It has a long-term earnings growth rate of 6.1%.
Conagra Brands Inc. (CAG - Free Report) delivered a positive average earnings surprise of 6.9% and has a long-term earnings growth rate of 7%.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>